MiniMed™ 780G system with 15-day Instinct sensor, made by Abbott
Anticipates and automatically delivers the insulin you need — quieting the what-ifs so you can own your every choice and every move.
Get started
Less counting, more living
With Meal Detection™ technology† making corrections in the background when carb counts are off‡ or you forget to tell the insulin pump you’re eating, you get more freedom, more spontaneity, and more confidence to live the way you want.
A system that does more
The system automatically adjusts and corrects§ sugar levels every 5 minutes to help keep you in range 24/7.
Get proven accuracy and a sleek all-in-one design with the Instinct sensor, made by Abbott.
The system requires as few as 6 device insertions a month with the 15-day Instinct sensor and 7-day Extended™ infusion set.¶#
Trust your Instinct
Combining the #1 sensor in the U.S. with the #1 pump in preventing highs and lows, based on user satisfaction,1-3 means you can be confident the system has your back. So you can own your every move.
Footnotes
† Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
‡ Refers to SmartGuard™ technology. Individual results may vary.
§ Refers to auto correct, which provides bolus assistance. Can deliver all correction doses automatically without user interaction, feature can be turned on and off.
◊ Due to inherent real-world study limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences.
¶ Based on usage of 2 Instinct sensors for 15 days each and 4 Extended Infusion Sets for 7 days each in a one-month period. More insertions may be required if Instinct sensor or Extended infusion set requires replacement before specified wear time.
# Fingersticks required in manual mode & to enter SmartGuard™. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard™.
References
1. Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed
2. Individual results may vary.
3. dQ&A US Patient Voice Q2 2025.p. 77. N=215
Important Safety Information: MiniMed™ 780G system with SmartGuard™ technology with Instinct™ sensor
The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G System includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.
The Instinct sensor can be used one time and has a life up to 15 days. The Instinct sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G system is operating in manual mode. All therapy adjustments in Manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Instinct sensor. The Instinct sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Only apply the sensor to the back of your upper arm. The sensor may not work properly in other areas.
The Medtronic MiniMed™ 780G System consists of the following devices: MiniMed™ 780G Insulin Pump and the Instinct sensor. The system requires a prescription from a healthcare professional.
WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.
WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.
© Medtronic. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image © Abbott. ™*Third–party brands are trademarks of their respective owners.